CADL
Price
$12.62
Change
-$0.16 (-1.25%)
Updated
Sep 8, 04:59 PM (EDT)
Capitalization
977.91M
58 days until earnings call
Intraday BUY SELL Signals
CTNM
Price
$16.73
Change
+$0.03 (+0.18%)
Updated
Sep 8, 12:23 PM (EDT)
Capitalization
628.27M
64 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CADL vs CTNM

CADL vs CTNM Comparison Chart in %
View a ticker or compare two or three
VS
CADL vs. CTNM commentary
Sep 08, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a Hold and CTNM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2026
Stock price -- (CADL: $12.78 vs. CTNM: $16.70)
Brand notoriety: CADL and CTNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 40% vs. CTNM: 79%
Market capitalization -- CADL: $977.91M vs. CTNM: $628.27M
CADL [@Biotechnology] is valued at $977.91M. CTNM’s [@Biotechnology] market capitalization is $628.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $138.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whileCTNM’s FA Score has 1 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • CTNM’s FA Score: 1 green, 4 red.
According to our system of comparison, CTNM is a better buy in the long-term than CADL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 2 TA indicator(s) are bullish while CTNM’s TA Score has 3 bullish TA indicator(s).

  • CADL’s TA Score: 2 bullish, 6 bearish.
  • CTNM’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CTNM is a better buy in the short-term than CADL.

Price Growth

CADL (@Biotechnology) experienced а -2.22% price change this week, while CTNM (@Biotechnology) price change was -2.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.39%. For the same industry, the average monthly price growth was +6.64%, and the average quarterly price growth was +2611.24%.

Reported Earning Dates

CADL is expected to report earnings on Nov 05, 2026.

CTNM is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (+2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CADL($978M) has a higher market cap than CTNM($628M). CADL YTD gains are higher at: 126.195 vs. CTNM (46.107). CTNM has higher annual earnings (EBITDA): -66M vs. CADL (-83.14M). CTNM has more cash in the bank: 237M vs. CADL (202M). CTNM has less debt than CADL: CTNM (6.57M) vs CADL (49.5M). CADL (0) and CTNM (0) have equivalent revenues.
CADLCTNMCADL / CTNM
Capitalization978M628M156%
EBITDA-83.14M-66M126%
Gain YTD126.19546.107274%
P/E RatioN/A26.40-
Revenue00-
Total Cash202M237M85%
Total Debt49.5M6.57M753%
TECHNICAL ANALYSIS
Technical Analysis
CADLCTNM
RSI
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
84%
Momentum
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
86%
Advances
ODDS (%)
Bullish Trend 27 days ago
85%
Bullish Trend 6 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 5 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CADL
Daily Signal:
Gain/Loss:
CTNM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JIGCX66.490.33
+0.50%
Janus Henderson Overseas C
VWELX47.36-0.09
-0.19%
Vanguard Wellington Inv
GAMPX16.51-0.05
-0.30%
GS Energy Infrastructure Fd P
BPAVX38.66-0.17
-0.44%
Boston Partners All Cap Value Inv
ZDIVX32.37-0.19
-0.58%
Zacks Dividend Investor

CTNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTNM has been loosely correlated with PMN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CTNM jumps, then PMN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTNM
1D Price
Change %
CTNM100%
-4.95%
PMN - CTNM
34%
Loosely correlated
-2.33%
LKFT - CTNM
33%
Loosely correlated
-1.83%
CADL - CTNM
32%
Poorly correlated
-1.46%
ZBIO - CTNM
31%
Poorly correlated
-0.12%
ZURA - CTNM
31%
Poorly correlated
+5.95%
More